These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 20959401)

  • 1. Inflammatory breast cancer: the disease, the biology, the treatment.
    Robertson FM; Bondy M; Yang W; Yamauchi H; Wiggins S; Kamrudin S; Krishnamurthy S; Le-Petross H; Bidaut L; Player AN; Barsky SH; Woodward WA; Buchholz T; Lucci A; Ueno NT; Cristofanilli M
    CA Cancer J Clin; 2010; 60(6):351-75. PubMed ID: 20959401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
    Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
    Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory breast cancer in the Netherlands; improved survival over the last decades.
    van Uden DJ; Bretveld R; Siesling S; de Wilt JH; Blanken-Peeters CF
    Breast Cancer Res Treat; 2017 Apr; 162(2):365-374. PubMed ID: 28138891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from an unusual case of inflammatory breast cancer.
    Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
    J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory breast cancer: what we know and what we need to learn.
    Yamauchi H; Woodward WA; Valero V; Alvarez RH; Lucci A; Buchholz TA; Iwamoto T; Krishnamurthy S; Yang W; Reuben JM; Hortobágyi GN; Ueno NT
    Oncologist; 2012; 17(7):891-9. PubMed ID: 22584436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.
    Yeh ED; Jacene HA; Bellon JR; Nakhlis F; Birdwell RL; Georgian-Smith D; Giess CS; Hirshfield-Bartek J; Overmoyer B; Van den Abbeele AD
    Radiographics; 2013; 33(7):2003-17. PubMed ID: 24224593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory breast cancer: early recognition and diagnosis is critical.
    Hester RH; Hortobagyi GN; Lim B
    Am J Obstet Gynecol; 2021 Oct; 225(4):392-396. PubMed ID: 33845027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory breast cancer: what progress have we made?
    Dawood S; Cristofanilli M
    Oncology (Williston Park); 2011 Mar; 25(3):264-70, 273. PubMed ID: 21548470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory breast cancer.
    Dushkin H; Cristofanilli M
    J Natl Compr Canc Netw; 2011 Feb; 9(2):233-40; quiz 241. PubMed ID: 21310844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presentation, management and outcome of inflammatory breast cancer cases in the UK: Data from a multi-centre retrospective review.
    Copson E; Shaaban AM; Maishman T; Moseley PM; McKenzie H; Bradbury J; Borley A; Brzezinska M; Chan SYT; Ching J; Cutress RI; Danial I; Dall B; Kerin M; Lowery AJ; Macpherson IR; Romics L; Sawyer E; Sharmat N; Sircar T; Vidya R; Pan Y; Rea D; Jones L; Eccles DM; Berditchevski F
    Breast; 2018 Dec; 42():133-141. PubMed ID: 30278369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on systemic treatment for newly diagnosed inflammatory breast cancer.
    Chainitikun S; Saleem S; Lim B; Valero V; Ueno NT
    J Adv Res; 2021 Mar; 29():1-12. PubMed ID: 33842000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment.
    Dawood S; Merajver SD; Viens P; Vermeulen PB; Swain SM; Buchholz TA; Dirix LY; Levine PH; Lucci A; Krishnamurthy S; Robertson FM; Woodward WA; Yang WT; Ueno NT; Cristofanilli M
    Ann Oncol; 2011 Mar; 22(3):515-523. PubMed ID: 20603440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
    Jacene HA; DiPiro PJ; Bellon J; Hu J; Cheng SC; Warren L; Schlosnagle E; Nakhlis F; Rosenbluth JM; Yeh E; Overmoyer B
    Breast Cancer Res Treat; 2020 Jun; 181(2):383-390. PubMed ID: 32318957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.
    Saigal K; Hurley J; Takita C; Reis IM; Zhao W; Rodgers SE; Wright JL
    Clin Breast Cancer; 2013 Oct; 13(5):335-43. PubMed ID: 23850216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
    Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
    Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of CNS metastases and survival in patients with inflammatory breast cancer.
    Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
    Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer.
    Menta A; Fouad TM; Lucci A; Le-Petross H; Stauder MC; Woodward WA; Ueno NT; Lim B
    Surg Clin North Am; 2018 Aug; 98(4):787-800. PubMed ID: 30005774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory breast cancer: The pathologists' perspective.
    Cserni G; Charafe-Jauffret E; van Diest PJ
    Eur J Surg Oncol; 2018 Aug; 44(8):1128-1134. PubMed ID: 29706301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory breast cancer: A review from our experience.
    Mele M; Sørensen AS; Bruun J; Funder JA; Tramm T; Bodilsen A; Nielsen HM; Christiansen PM
    Breast Dis; 2019; 38(2):47-55. PubMed ID: 31256114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes: A population-based study from the SEER program.
    Li J; Xia Y; Wu Q; Zhu S; Chen C; Yang W; Wei W; Sun S
    Oncotarget; 2017 Jul; 8(30):49370-49379. PubMed ID: 28472761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.